منابع مشابه
Dyslipidemia and the metabolic syndrome.
Lipid-related epidemiology A number of presentations at the June American Diabetes Association (ADA) meeting addressed aspects of lipid therapy of persons with diabetes. Brown et al. (abstract 929) reported the correlation between fasting lipids and HbA1c in 11,938 persons with diabetes in the Kaiser Permanente Northwest population. Comparing persons with no, one, and two high–cardiovascular di...
متن کاملAtherogenic dyslipidemia and the metabolic syndrome.
INTRODUCTION High serum cholesterol has been known as being a main risk factor for coronary heart disease (CHD). A number of types of evidence support the cholesterol-CHD link, these include researches in laboratory animals, epidemiological studies, findings of premature CHD in genetic forms of hypercholesterolemia, laboratory investigations, and clinical trials of cholesterol-lowering therapy....
متن کاملDevastating metabolic consequences of a life of plenty: focus on the dyslipidemia of overnutrition.
Although undernutrition and starvation continue to affect a substantial portion of the world's population, billions of people in both developed and developing countries are affected by the opposite problem: consumption of calories that exceed their daily energy expenditure, a condition of overnutrition. The body's response to a positive net energy balance is to store energy, predominantly as tr...
متن کاملATVB In Focus Metabolic Syndrome and Atherosclerosis
Although the epidemic of obesity has been accompanied by an increase in the prevalence of the metabolic syndrome, not all obese develop the syndrome and even lean individuals can be insulin resistant. Both lean and obese insulin resistant individuals have an excess of fat in the liver which is not attributable to alcohol or other known causes of liver disease, a condition defined as nonalcoholi...
متن کاملATVB In Focus Metabolic Syndrome and Atherosclerosis
There is currently substantial confusion between the conceptual definition of the metabolic syndrome and the clinical screening parameters and cut-off values proposed by various organizations (NCEP-ATP III, IDF, WHO, etc) to identify individuals with the metabolic syndrome. Although it is clear that in vivo insulin resistance is a key abnormality associated with an atherogenic, prothrombotic, a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Obesity
سال: 2006
ISSN: 1930-7381,1930-739X
DOI: 10.1038/oby.2006.281